Research using mouse models have contributed essential knowledge toward our current understanding of how the human immune system functions. One key difference between humans and typical laboratory mice, however, is exposure to pathogens in their respective environments.
INTRODUCTION
The laboratory mouse has been utilized as a powerful biological research model for more than a century. For a multitude of reasons including rapid and effective breeding, the ease and low cost of housing, and their high genetic homology to humans, mice have become an indispensable tool for researchers. The painstaking generation of inbred lines was followed by increasingly more powerful ways to manipulate the genome of mice-building on transgenic and gene knockout approaches, the use of new technologies such as CRISPR-Cas9 have further revolutionized the ability to generate novel mouse strains within a few weeks. 1 Thus, the vast array of genetically manipulated mice available has further cemented their usage as an essential tool for biomedical research.
While mice have undeniable strengths for studying human disease, it can be easy to overlook their disadvantages when designing research studies. Some argue that the limitations of mouse model systems have led to a costly number of promising therapeutics in preclinical trials Abbreviations: CLP, cecal ligation puncture; EAE, experimental autoimmune encephalomyelitis; MPECs, memory precursor effector cells; SLECs, short-lived effector cells; SPF, specific pathogen-free ultimately failing to effectively treat humans suffering from analogous diseases. [2] [3] [4] [5] Many possible causes could ultimately lead to disparities between the human and murine immune response, the ones most typically cited being core genetic differences between the species, lifespan, and survival characteristics and the genetic heterogeneity present within humans as a highly outbred population compared to inbred laboratory mice. Until recently, however, there has been less focus on how much the different environments in which laboratory mice and free-living humans exist contributes to discordance between the species, especially in the context of the immune system.
Researchers have now begun to modify the traditional murine model system in hopes of enhancing the translatability of scientific findings to humans. While not all differences between mice and humans can be rectified, recent studies indicate that alterations in microbial exposure show promise at improving translation from murine models. [6] [7] [8] [9] Today, the standard mouse colony is housed under specific pathogen-free (SPF) conditions. This means mice are regularly screened for and protected from numerous natural mouse pathogens in order to enhance the reproducibility of laboratory research. This approach, developed in the 1950s has been largely successful in standardizing experiments and enhancing confidence in interpreting results. 10, 11 Ongoing or previously resolved infections add an J Leukoc Biol. 2019;105:73-79. c 2018 Society for Leukocyte Biology 73 www.jleukbio.org F I G U R E 1 Cohousing with wild mice. Cohousing of SPF mice with outbred wild mice results in the transfer of pathogens and commensal microbes to the SPF animals. Given time, these naturally acquired bacterial, viral, and parasitic infections change the immune system of the cohoused mice. C57BL/6 mice shift from a naïve immune status resembling a newborn infant, to a more mature, antigen experienced immune system resembling adults. These changes alter both the composition and functionality of the murine immune system uncontrolled variable that could confound results to experimental treatments and procedures. It is clear why an immunologist studying a particular disease would like assurances that they are in fact recording responses to the administered manipulation, and not an unanticipated secondary effect. Furthermore, as spontaneous and genetically manipulated immunocompromised mouse strains were developed it was quickly appreciated that colonies of such animals maintained under "conventional" housing conditions could be devastated by many of the microbes that constitute the list of "Specific Pathogens." However, as the field has progressed to cleaner and cleaner research environments (including generation of "germ-free" and even "antigen-free" mouse strains), we may have unknowingly generated important caveats to the interpretation of our experiments. [12] [13] [14] Humans do not exist in pathogen-free environments. In fact, from birth we are bombarded with both commensals and a variety of pathogens, and it is becoming increasingly clear that these shape human health and immune competency. Analysis comparing laboratory and wild mice reveal quite robust differences between their respective immune systems-for example, compared to laboratory mice, wild animals display a more activated immune system with increased serum antibody levels and numbers of circulating myeloid cells. 15, 16 While these reports illustrate the potential value of examining the immune response in wild mice, such research would necessarily entail sacrificing the genetic homogeneity (and manipulability) of inbred mouse strains, as well as pose a limit on the ability to regulate numerous variables (age, breeding history, nutrition, prior immunological exposures, etc.), which could make the venture even less well controlled than comparable human studies. To combat such restrictions, various groups have developed approaches that enable researchers to "have their cake and eat it"-use genetically defined inbred mouse strains that are exposed to a more natural constellation of commensal and pathogenic microbes. Studies in such animals have already illustrated the substantial and sometimes counterintuitive ways in which homeostasis and reactivity of the immune system is impacted by diverse prior immunological experience. We will summarize recent findings in 4 such mouse models of microbial exposure, discussing the pros and cons of each approach and the implications of their findings on our understanding of the immune system.
MODELS FOR INTRODUCING DIVERSE MICROBIAL EXPOSURE TO LABORATORY STRAINS OF MICE

Microbe transfer through cohousing
To address the role environment plays on shaping the immune system, Beura et al. studied mice raised outside of a traditionally "clean" SPF environment. 6 The CD8 T cell pool in captured feral and pet store raised mice was shown to dramatically differ in composition relative to SPF laboratory animals. Most notably, the SPF raised C57BL/6 mouse T cell population is primarily composed of naïve T cells (CD44 low CD62L hi ). In contrast, in mice obtained from pet stores the T cell repertoire was skewed toward an abundance of effector/memory T cells (CD44 hi CD62L low ) and many of the CD8+ T cells in this population expressed high levels of granzyme B and KLRG1, indicative of a population with immediate cytolytic potential. 17 Interestingly, when compared to human blood, the phenotype of T cell subsets found in SPF mice closely matched those of neonatal human blood, whereas the populations in pet store and feral mice were more similar to those found in adult PBMCs. 6 It was possible that the distinct representation of T cell subpopulations in wild and pet store mice versus SPF animals could arise from the particular genetic traits of the outbred animals or arise as a consequence of their habitat or feeding habits. However, similar T cell subsets developed in laboratory mice after they were cohoused with pet store animals (under laboratory conditions), suggesting the role of transmissible microorganisms (commensals and/or pathogens). 6 Serological screening showed the transfer of multiple "SPF-designated" viruses, bacteria, and parasites from the pet store animals to the cohoused laboratory animals ( Fig. 1 ). After 60 days in the same cage as pet store animals, T cells in the cohoused inbred mice took on a predominant effector/memory-like phenotype (CD44 hi CD62L low ) and also largely upregulated KLRG1 and granzyme B, while reducing CD27 and CXCR3. Cohoused mice also developed increased tissue resident memory T cells in various nonlymphoid tissues. Alterations in immune populations were not limited to conventional T cells-innate lymphoid cells and T cells were altered in representation within nonlymphoid sites, and there was a notable increase in circulating antibodies of numerous isotypes.
The preponderance of naïve-phenotype T cells in laboratory mice raised under SPF conditions resembles the phenotype of T cells present in human blood at birth, prior to robust microbial exposure.
However, adult humans who have experienced numerous immune responses through both natural infections and vaccination, develop increased frequencies of effector memory T cells (Tem and Temra), and more closely resemble cohoused mice. Transcriptional analysis of blood cells revealed induction of the IFN-I signaling pathway in pet store animals and inbred mice subject to cohousing for 60 days. 6 Likewise, analysis of blood cells in neonatal versus adult humans showed increased representation of the IFN-I signature in immunologically experienced adults, reinforcing the parallels with pet store and cohoused mice. Induction of IFN-I signaling has the capacity to induce a variety of effects on numerous innate and adaptive cell types in the immune system, leading to either improved host defense or immunosuppression depending on the timing of IFN-I production and the infectious model system. 18 The changes seen in the composition of CD8 T cell pool in cohoused mice could be influenced by direct stimulation through IFNAR or secondarily through activation of antigen presenting cells, which are then better at priming the adaptive immune response.
The immune changes in cohoused mice translated into a more functional immune response when challenged with novel pathogens.
Cohoused mice were more efficient at clearance of both bacterial and parasitic infections. This enhanced protection may be due to increased numbers of effector memory T cells in cohoused mice. KLRG1+ CD27effector memory CD8 T cells are rapid and efficient responders to infection, and an increase in their numbers may lead to a more efficacious immune response to acute infection. 17 Additionally, bystander (TCR-independent) activation of CD8 T cells through cytokine stimulation enhances pathogen clearance. 19, 20 Cohoused animals have both an altered inflammatory environment and an elevated number of memory CD8 T cells from previous infections. 6 Alternatively, the enhanced protection seen in cohoused animals could result from alterations to the innate immune system. Future studies aimed at determining whether changes in the adaptive or innate immune system in cohoused mice mediate enhanced immunity are essential to understand the mechanisms of action at work in this model. When challenged with LCMV Armstrong, cohoused mice generate reduced memory precursor effector cells (MPECs) and increased short-lived effector cells (SLECs), suggesting alterations in the skewing of CD8 T cell differentiation following an acute non-cytopathic infection.
Whether additional infectious or vaccine challenges will similarly generate increased numbers of SLECs remains to be determined. Similarly, the ability of cohoused mice to more efficiently clear pathogens (and the mechanistic basis behind this accomplishment) needs to be comprehensively explored in multiple infectious models, and include robust assessments of both innate and adaptive immunity.
Sequential infection
One limitation to natural pathogen transfer via cohousing of pet store and inbred mice is the lack of control associated with which infections are passed to the laboratory mice, increasing experimental variability. There are an unpredictable number of ongoing infections that each pet store mouse has when it is purchased and combined with the laboratory animals, and the timing of the transfer of such pathogens is likely to be asynchronous. While one could argue this makes the murine model more closely in line with the diversity of human immunological experience, there is also a benefit to the reproducibility of knowing which infections your experimental mice receive, and when they received them. Pathogen transfer from cohousing with pet store mice resulted in 22% death for C57BL/6 mice. 6 The variability in transferred pathogens and elevated mortality rate must be consid- regimen. Similar to cohousing, this process also induced immune cell phenotypic changes, which were more reflective of adult human immune cells. 7 After sequential infection exposure, mice generated an antibody response to the yellow fever vaccine, which was modestly accelerated compared to SPF mice. Using the same approach as Beura and colleagues, these authors compared the gene expression profile of mice after their infection sequence and found an analogous change in expression away from SPF mice (and human cord blood) to more closely match pet store mice and adult humans. 7 Using this approach offers the flexibility to alter the type of infections, sequence of exposure, and timing between infections to study these effects on the immune system. However, controlling these parameters moves away from the "natural" transmission method of the cohousing model in which exposure to multiple microbes is likely to be happening simultaneously through a variety of routes, and entails prior selection of a set of pathogens, which are deemed appropriate to reflect the microbial diversity of a natural population. Hence, while appealing in its suitability for precise manipulation, it is not yet clear that a predefined sequential infection model will yield the same level of immunological experience needed to optimally mimic immune experience in adult humans.
Microbiome transfer
In recent years, there has been an increasing appreciation for the role host-microbiome interactions play in shaping many disease states. 21, 22 The majority of host interactions with bacteria take place F I G U R E 2 Wild microbiome transfer. Colonization of germ-free mice with wild mouse microbiomes results in a diversified gut microbiota that is stably transferrable within a colony throughout multiple generations. First, wild mice were captured and their microbiomes were screened and biobanked to be used as donors. Iliocecal material was transferred (from donors that were found to be pathogen-free) via oral gavage into germfree laboratory mice to colonize the gut. Pregnant wild microbiome female mice passed their new microbiome to progeny to establish a stable colony of animals containing a wild microbiota. For comparison, SPF ileocecal material was used to reconstitute germ-free animals with a standard laboratory mouse microbiome. Wild reconstituted mice developed a diverse gut microbiome and systemic changes to the immune system not with pathogenic organisms during infection, but rather with the commensals contained in the microbiome. A number of interesting studies have highlighted how microbial colonization alters the immune response throughout the host. Segmented filamentous bacteria is one example, whose presence in the gut microbiome promotes a Th17 skewing of the immune system. 23 In different contexts this either promotes experimental autoimmune encephalomyelitis (EAE), or protects from it (type 1 diabetes). 24, 25 In contrast, introduction of Clostridium species to the gut promotes the differentiation of Treg cells and protects mice from colitis. 26 A murine model of sepsis using cecal ligation puncture (CLP) to perforate the cecum and release bacteria and induce septic shock, demonstrated differing outcomes using mice from different vendors. 27 One hypothesis to explain this phenotype is that the differing microbiome compositions of mice purchased from different vendors have varying microbiome composition. Through cohousing, SPF mice from 1 vendor were able to protect previously susceptible mice from sepsis following CLP. The authors were able to demonstrate that protection stemmed from the transfer of gut bacteria from protected mice. Transfer of unique commensal bacteria led to the induction of protective serum IgA production that shielded the formerly susceptible mice from sepsis. 28 Given the gut microbiome's ability to alter host immunity and its known variation among sources of laboratory mice, Rosshart et al.
asked whether SPF housing conditions altered the natural gut colonization of laboratory mice, and if so does this impact the response to infection. 8 This study showed that SPF housed mice have a different microbiota than wild mice. The microbiome of vendor purchased mice exhibited significantly reduced diversity, skewed largely to the firmicutes phylum. Using fecal transplantation via oral gavage, the researchers were able to reconstitute germ-free laboratory mice with a more diverse, wild gut microbiome. This reconstituted microbiome could be transferred to future progeny allowing the authors to generate a stable colony of laboratory mice containing wild microbiome ( Fig. 2) . Intriguingly, mice reconstituted with the more diverse microbiome, had an advantage in clearing influenza viral infection. A "wild" gut microbiome also reduced inflammatory cytokine levels in the host, which contributed to diminished development of invasive colorectal tumors. This approach demonstrates that the gut microbiome of wild mice provides key immune advantages against both pathogen infection and cancer. However, whether reconstitution with "wild microbiota" led to changes in the representation or activation state of populations of immunologically relevant cells was not explored making it hard to put these studies in context of the other models discussed.
"Rewilding"
Another novel approach toward normalizing environmental factors relies upon "rewilding" of laboratory mice by creating an outdoor housing area for mice to interact with a minimally controlled environment. 9 The exposure to the natural environment (and the microbes within it) was shown to diversify the contents of the gut microbiome. In this study, nematode worms grew more rapidly in mice that had been rewilded outdoors compared to laboratory, SPF-maintained mice. Effective immunity to nematodes is particularly driven by a Th2 immune response. The authors show that rewilded mice have a CD4 T cell population skewing away from production of Th2 cytokines (as measured by IL-13) and toward Th1 cytokines (as measured by IFN-). This result implies that mice may not simply have a pervasively improved immune system with a more natural and diverse gut microbiome, but that it may preferentially improve distinct types of immune responses (i.e., Th1 responses). This would account for both the enhanced response to influenza and the poorer control of nematode infection after diversifying the microbiome.
TA B L E 1
Comparing microbial exposure models. The mouse models discussed in this review offer numerous methods for generating a more natural environment of microbial exposure. Each of these systems offers strengths and weaknesses (between each other and standard SPF practices) that must be considered based on the experimental questions at hand. The current status of findings from these different approaches is summarized
SPF mouse
Wild mouse
Cohoused mouse
Sequential infection
Wild microbiome transfer Rewilding
Genetically homogeneous X X X X X Transgenic mouse compatible X X X X X Controlled infection history X X X Natural pathogen exposure X X X Diverse microbiome X ? ? X X
Experienced immune system X X X ? ?
E n h a n c e d p a t h o g e n p r o t e c t i o n -X X X X ?
Enhanced anticancer immunity -?
? ?
X ?
The rewilding model would benefit from additional studies aimed to reconcile the perceived similarities and differences with the other methods described in this review. For example, in addition to microbiome changes described it seems reasonable that the outdoor setting would expose the animals to other infectious agents. Identifying these infections could help to identify if the phenotype observed is a result of pathogen transfer or microbiome changes. Furthermore, the experiments performed thus far strictly examine response to helminths, an infectious agent known to initiate a Th2 immune response. It would be interesting to identify the protective capacity of rewilded animals to respond to viral or bacterial challenges. Conversely, it would also be advantageous to learn more about the Th2 response in cohoused mice, sequential infection, or microbiome transfer models. Future work on a broader range of pathogens is necessary in each of these models of microbial exposure to better define the unique and consistent findings within each of these systems.
FUTURE OPPORTUNITIES FOR MOUSE MODELS WITH MICROBIAL EXPOSURE
The above systems attempt to analyze the immune system from a novel approach of increasing the exposure of SPF mice to microorganisms ( Table 1) The impact of previous microbial exposure on vaccine efficacy has yet to be explored and may be highly relevant in the context of childhood vaccination (more represented by SPF mice) versus the likelihood of successful adult vaccination (more represented by cohoused mice). To date, studies on the effects of coinfection on vaccine efficacy have yielded mixed results. 32 Many of the diseases in which vaccine development has stalled, primarily afflict areas of the developing world that are more prone to recurrent and complex infections. This adds an additional hurdle toward developing an efficacious vaccine.
For example, it has been exceedingly difficult to generate vaccines to induce sterilizing immunity to malaria and tuberculosis. 33, 34 In humans, infection with helminths has been associated with an increase in both frequency and severity of malaria. 35, 36 To complicate matters, human cohorts have also shown a protective capacity of worm infections on the development malaria. 37 In SPF mice, an experimental vaccine shown to be efficacious, lost its protective value in mice coinfected with nematodes. 38 Additionally, prior infection history has been demonstrated to alter the immune response to tuberculosis as well as bacillus Calmette-Guérin, the tuberculosis vaccine. Both prior and coinfection of mice with influenza during tuberculosis infection result in decreased antigen-specific T cell responses and reduced tuberculosis bacterial clearance. 39 Interestingly, reduced tuberculosis clearance during coinfection was dependent upon IFN-I signaling. 40 These examples highlight the important point that each individual infection cannot be treated as an isolated incident, but rather translates to part of the entire host immune experience that refines the responsiveness of the immune system. Using microbially exposed laboratory strains of mice provides a unique opportunity to harness the strengths of the murine model system (and the numerous genetically altered strains commercially available) and pair them with an immune system that more accurately recapitulates wild mice and adult humans. This experimental design provides an opportunity to reduce differences between humans and mice by normalizing environmental effects of microbe exposure.
Whether prior immune experience universally enhances resistance to all novel microbial encounters and cancers or whether improved immunity is specific for certain situations remains to be fully studied.
Utilizing mice with a normalized microbial environment could provide a useful stepping stone between SPF mice to humans. Before spending the considerable resources to generate a large-scale trial, incorporating a screening in mice which better replicate humans (via microbial exposure) could be more useful to predict the success of potential clinical therapies. While more work needs to be done, the expectation for increased translatability from mice to men is not unrealistic. 
